Table II.
N1/N2 | Disease Model | Subjects | Key Findings | References |
---|---|---|---|---|
N1 | Tuberculous pleurisy | Guinea pigs | TGF-β neutralization increases neutrophils in pleural exudate. | Allen et al., 2008 [69] |
N1 | Tumor | Mouse | TGF-β blockade reduces tumor metastasis. | Kazemfar et al., 2009 [70] |
N2 | NA | Human | Regulatory T cells inhibit neutrophils survival and their ROS and cytokine production, which is confirmed at least partially mediated by and IL-10. | Lewkowicz et al., 2006 [65] |
N2 | NA | Human | TGF-β1 suppresses neutrophil degranulation to prevent them from initiating an inflammatory response. | Shen et al., 2007 [64] |
N2 | Stroke | Mouse | PPAR-γ activation with rosiglitazone induces “N2” neutrophils. | Cuartero et al. 2013 [63] |
N/N2 | Tumor | Mouse | Blockade of TGF-β promotes tumor-associated neutrophils with an anti-tumor phenotype, which is referred as N1. TGF-β in tumor microenvironment induces a pro-tumor neutrophils, N2. | Fridlender et al., 2009 [62] |
NA, not available